• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青少年非酒精性脂肪性肝病与肠道微生物群:两者有关系吗?

Non-alcoholic fatty liver disease and the gut microbiota in adolescents: is there a relationship?

机构信息

Pediatric Department, Faculty of Medicine, Tanta University, Tanta, Egypt.

Tropical Medicine Departments, Faculty of Medicine, Tanta University, Tanta, Egypt.

出版信息

BMC Pediatr. 2024 Nov 29;24(1):779. doi: 10.1186/s12887-024-05268-y.

DOI:10.1186/s12887-024-05268-y
PMID:39609733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11606091/
Abstract

BACKGROUND

Despite the increasing prevalence of nonalcoholic fatty liver disease (NAFLD), the pathophysiology is still not fully understood. Recent evidence suggests that the gut microbiota may play a role in the pathophysiology of NAFLD and may also offer new therapeutic options.

METHODS

This prospective cross-sectional study included 100 consecutive newly diagnosed obese patients (BMI ≥ 95th percentile), aged 14-18 years with NAFLD (confirmed by ultrasound), persistently elevated levels of alanine aminotransferase (ALT) greater than 60 U/L for 1-6 months, and 100 healthy controls. We evaluated changes in the gut microbiota in NAFLD adolescents compared with healthy controls.

RESULTS

According to the multiple logistic regressions, the variables associated with NAFLD were the presence of Clostridium difficile, the presence of Salmonella spp., a greater abundance of Bifidobacterium and Prevotella, and a lower abundance of Lactobacillus.

CONCLUSION

Changes in the gut microbiota occur in adolescents with NAFLD compared with healthy individuals, which may be useful for identifying youths who are amenable to gut microbiota-based interventions.

CLINICAL TRIAL NUMBER

Not applicable.

摘要

背景

尽管非酒精性脂肪性肝病 (NAFLD) 的患病率不断增加,但发病机制仍未完全阐明。最近的证据表明,肠道微生物群可能在 NAFLD 的发病机制中起作用,并且还可能提供新的治疗选择。

方法

这项前瞻性横断面研究纳入了 100 例连续新诊断的肥胖患者(BMI≥第 95 百分位数),年龄在 14-18 岁之间,患有 NAFLD(超声证实),丙氨酸氨基转移酶(ALT)持续升高>60 U/L 1-6 个月,且有 100 名健康对照者。我们评估了 NAFLD 青少年与健康对照组之间肠道微生物群的变化。

结果

根据多因素逻辑回归分析,与 NAFLD 相关的变量包括艰难梭菌、沙门氏菌属的存在、双歧杆菌和普雷沃氏菌丰度增加以及乳酸杆菌丰度降低。

结论

与健康个体相比,NAFLD 青少年的肠道微生物群发生了变化,这可能有助于识别适合基于肠道微生物群的干预的青少年。

临床试验编号

不适用。

相似文献

1
Non-alcoholic fatty liver disease and the gut microbiota in adolescents: is there a relationship?青少年非酒精性脂肪性肝病与肠道微生物群:两者有关系吗?
BMC Pediatr. 2024 Nov 29;24(1):779. doi: 10.1186/s12887-024-05268-y.
2
Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis.非酒精性脂肪性肝病患者肠道微生物群的组成改变:一项系统评价和Meta分析。
Lipids Health Dis. 2021 Feb 26;20(1):22. doi: 10.1186/s12944-021-01440-w.
3
[Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].非酒精性脂肪性肝病患者肠道微生物群与生化指标的相关性分析
Zhonghua Gan Zang Bing Za Zhi. 2019 May 20;27(5):369-375. doi: 10.3760/cma.j.issn.1007-3418.2019.05.009.
4
Normal serum alanine aminotransferase and non-alcoholic fatty liver disease among Korean adolescents: a cross-sectional study using data from KNHANES 2010-2015.韩国青少年的正常血清丙氨酸转氨酶与非酒精性脂肪性肝病:一项使用2010 - 2015年韩国国家健康与营养检查调查(KNHANES)数据的横断面研究
BMC Pediatr. 2018 Jul 5;18(1):215. doi: 10.1186/s12887-018-1202-z.
5
Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.了解肠道微生物组和微生物代谢物在非酒精性脂肪性肝病中的作用:当前的证据和观点。
Biomolecules. 2021 Dec 31;12(1):56. doi: 10.3390/biom12010056.
6
Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者的肠道菌群失调。
Hepatobiliary Pancreat Dis Int. 2017 Aug 15;16(4):375-381. doi: 10.1016/S1499-3872(17)60019-5.
7
Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan.台湾经活检证实的非酒精性脂肪性肝病患者的肠道微生物失调:一项横断面研究。
Nutrients. 2020 Mar 19;12(3):820. doi: 10.3390/nu12030820.
8
The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.非酒精性脂肪性肝病的严重程度与肠道菌群失调及肠道微生物群代谢功能的改变有关。
Hepatology. 2016 Mar;63(3):764-75. doi: 10.1002/hep.28356. Epub 2016 Jan 13.
9
Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease.与儿童非酒精性脂肪性肝病患者的脂肪性肝炎和中重度纤维化相关的微生物组特征。
Gastroenterology. 2019 Oct;157(4):1109-1122. doi: 10.1053/j.gastro.2019.06.028. Epub 2019 Jun 27.
10
Multi-omics analyses of the gut microbiota and metabolites in children with metabolic dysfunction-associated steatotic liver disease.代谢功能障碍相关脂肪性肝病患儿肠道微生物群和代谢物的多组学分析
mSystems. 2025 Apr 22;10(4):e0114824. doi: 10.1128/msystems.01148-24. Epub 2025 Mar 14.

引用本文的文献

1
Therapeutic Targeting of PPARγ in Nonalcoholic Fatty Liver Disease: Efficacy, Safety, and Drug Development.非酒精性脂肪性肝病中PPARγ的治疗靶点:疗效、安全性与药物研发
Drug Des Devel Ther. 2025 Aug 22;19:7293-7319. doi: 10.2147/DDDT.S524893. eCollection 2025.
2
Gut microbiota in liver diseases: initiation, development and therapy.肝脏疾病中的肠道微生物群:起始、发展与治疗
Front Med (Lausanne). 2025 Jun 4;12:1615839. doi: 10.3389/fmed.2025.1615839. eCollection 2025.

本文引用的文献

1
infection and gut microbiota in adolescents: Is there a relation?青少年感染与肠道微生物群:二者有关系吗?
J Biosci. 2024;49.
2
Intestinal Microbes in Autoimmune and Inflammatory Disease.肠道微生物与自身免疫和炎症性疾病
Front Immunol. 2020 Dec 23;11:597966. doi: 10.3389/fimmu.2020.597966. eCollection 2020.
3
Pathophysiology of Inflammatory Bowel Diseases.炎症性肠病的病理生理学
N Engl J Med. 2020 Dec 31;383(27):2652-2664. doi: 10.1056/NEJMra2002697.
4
Gut Microbiota in Intestinal and Liver Disease.肠道微生物群与肠道和肝脏疾病
Annu Rev Pathol. 2021 Jan 24;16:251-275. doi: 10.1146/annurev-pathol-030320-095722. Epub 2020 Nov 24.
5
Incidence of Nonalcoholic Fatty Liver Disease in Children: 2009-2018.儿童非酒精性脂肪性肝病的发病率:2009-2018 年。
Pediatrics. 2020 Dec;146(6). doi: 10.1542/peds.2020-0771.
6
Gut microbiota in human metabolic health and disease.人体肠道微生物群与代谢健康和疾病。
Nat Rev Microbiol. 2021 Jan;19(1):55-71. doi: 10.1038/s41579-020-0433-9. Epub 2020 Sep 4.
7
Programing of an Intravascular Immune Firewall by the Gut Microbiota Protects against Pathogen Dissemination during Infection.肠道微生物群通过编程形成血管内免疫防火墙,防止感染期间病原体传播。
Cell Host Microbe. 2020 Nov 11;28(5):660-668.e4. doi: 10.1016/j.chom.2020.07.014. Epub 2020 Aug 17.
8
Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate.膳食果糖通过微生物群衍生的乙酸促进肝脏脂肪生成。
Nature. 2020 Mar;579(7800):586-591. doi: 10.1038/s41586-020-2101-7. Epub 2020 Mar 18.
9
A Microbial Signature Identifies Advanced Fibrosis in Patients with Chronic Liver Disease Mainly Due to NAFLD.一种微生物特征可识别主要由非酒精性脂肪性肝病引起的慢性肝病患者的晚期纤维化。
Sci Rep. 2020 Feb 17;10(1):2771. doi: 10.1038/s41598-020-59535-w.
10
Distinct Polysaccharide Utilization Profiles of Human Intestinal Prevotella copri Isolates.人类肠道普雷沃氏菌分离株的独特多糖利用谱。
Cell Host Microbe. 2019 Nov 13;26(5):680-690.e5. doi: 10.1016/j.chom.2019.10.013.